UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

Biochemical journal, 2006-02, Vol.393 (Pt 3), p.609-618

2006

Volltextzugriff (PDF)

The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy

Molecular cancer therapeutics, 2017-10, Vol.16 (10), p.2223-2233

2017

Volltextzugriff (PDF)

Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion

Journal of cellular biochemistry, 2008-04, Vol.103 (6), p.1783-1797

2008

Volltextzugriff (PDF)

Make Good Change

ITE journal, 2023-10, Vol.93 (10), p.30-32

Sanderson, Michael P

2023

Volltextzugriff (PDF)

To Save Lives and Create Healthy Communities: An ITE Member's Responsibilities

ITE journal, 2023-01, Vol.93 (1), p.42-46

Sanderson, Michael P

2023

Volltextzugriff (PDF)

Exosomes: From biogenesis and secretion to biological function

Immunology letters, 2006-11, Vol.107 (2), p.102-108

2006

Volltextzugriff (PDF)

SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations

iScience, 2020-12, Vol.23 (12), p.101832-101832, Article 101832

2020

Volltextzugriff (PDF)

Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors

Growth factors (Chur, Switzerland), 2006, Vol.24 (2), p.121-136

2006

Volltextzugriff (PDF)

ADAM10 Mediates Ectodomain Shedding of the Betacellulin Precursor Activated by p-Aminophenylmercuric Acetate and Extracellular Calcium Influx

The Journal of biological chemistry, 2005-01, Vol.280 (3), p.1826-1837

2005

Volltextzugriff (PDF)

Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma

The Journal of pharmacology and experimental therapeutics, 2023-01, Vol.384 (1), p.163-172

2023

Volltextzugriff (PDF)

FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response

European journal of cancer (1990), 2021-07, Vol.151, p.136-149

2021

Volltextzugriff (PDF)

M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models

Molecular cancer therapeutics, 2021-08, Vol.20 (8), p.1378-1387

2021

Volltextzugriff (PDF)

Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance

Molecular cancer therapeutics, 2020-04, Vol.19 (4), p.1018-1030

2020

Volltextzugriff (PDF)

Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)

Journal of medicinal chemistry, 2021-07, Vol.64 (14), p.10230-10245

2021

Volltextzugriff (PDF)

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13), p.3497-3509

2018

Volltextzugriff (PDF)

Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: Implications for regulation of IgE-mediated degranulation

Molecular immunology, 2010-11, Vol.48 (1-3), p.171-178

2010

Volltextzugriff (PDF)

L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells

Gynecologic oncology, 2007-02, Vol.104 (2), p.461-469

2007

Volltextzugriff (PDF)

An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitor

Cancer chemotherapy and pharmacology, 2017-03, Vol.79 (3), p.545-558

2017

Volltextzugriff (PDF)

Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo

European journal of immunology, 2011-11, Vol.41 (11), p.3208-3218

2011

Volltextzugriff (PDF)

A comprehensive pharmacokinetic/pharmacodynamics analysis of the novel IGF1R/INSR inhibitor BI 893923 applying in vitro, in vivo and in silico modeling techniques

Cancer chemotherapy and pharmacology, 2016-06, Vol.77 (6), p.1303-1314

2016

Volltextzugriff (PDF)

721 Ongoing phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A816-A816

2023

Volltextzugriff (PDF)

Hydrogen peroxide and endothelin-1 are novel activators of betacellulin ectodomain shedding

Journal of cellular biochemistry, 2006-10, Vol.99 (2), p.609-623

2006

Volltextzugriff (PDF)

Abstract PL06-01: Discovery of BI-3406: A potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.PL06-01-PL06-01

2019

Volltextzugriff (PDF)

Abstract C133: Effective targeting of KRAS-driven tumors by the first-in-class, orally bioavailable SOS1::KRAS inhibitor BI-3406

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.C133-C133

2019

Volltextzugriff (PDF)

1 – 25 von 292

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(263)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(176)
Humans
(114)
Female
(64)
Animals
(60)
Male
(57)
Biological And Medical Sciences
(50)
Medical Sciences
(34)
Adult
(28)
Middle Aged
(28)
Environmental Sciences & Ecology
(27)
Mice
(24)
Physical Sciences
(23)
Aged
(22)
Fundamental And Applied Biological Sciences. Psychology
(22)
Genetics & Heredity
(21)
Science & Technology - Other Topics
(20)
Ecology
(19)
Multidisciplinary Sciences
(19)
Genomes
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44

The IGF1R/INSR Inhibitor BI 885578 Selectively Inhibits Growth of IGF2-Overexpressing Colorectal Cancer Tumors and Potentiates the Efficacy of Anti-VEGF Therapy

Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion

Make Good Change

BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition

To Save Lives and Create Healthy Communities: An ITE Member's Responsibilities

Exosomes: From biogenesis and secretion to biological function

SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations

Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors

ADAM10 Mediates Ectodomain Shedding of the Betacellulin Precursor Activated by p-Aminophenylmercuric Acetate and Extracellular Calcium Influx

Translational PK/PD Modeling of Tumor Growth Inhibition and Target Inhibition to Support Dose Range Selection of the LMP7 Inhibitor M3258 in Relapsed/Refractory Multiple Myeloma

FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response

M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models

Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance

Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)

Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage

Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: Implications for regulation of IgE-mediated degranulation

L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells

An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitor

Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo

A comprehensive pharmacokinetic/pharmacodynamics analysis of the novel IGF1R/INSR inhibitor BI 893923 applying in vitro, in vivo and in silico modeling techniques

721 Ongoing phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors

Hydrogen peroxide and endothelin-1 are novel activators of betacellulin ectodomain shedding

Abstract PL06-01: Discovery of BI-3406: A potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors

Abstract C133: Effective targeting of KRAS-driven tumors by the first-in-class, orally bioavailable SOS1::KRAS inhibitor BI-3406

Suchergebnisse filtern